H. Asnagli

Stability and commitment in T helper cell development.

H. Asnagli, K. Murphy, Hélène Asnagli, 2001, Current opinion in immunology.

Cutting Edge: Identification of an Alternative GATA-3 Promoter Directing Tissue-Specific Gene Expression in Mouse and Human1

H. Asnagli, K. Murphy, M. Afkarian, 2002, The Journal of Immunology.

Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis

A. Foussat, H. Asnagli, C. Jorgensen, 2014, Arthritis Research & Therapy.

Gene Expression in Mouse and Human GATA-3 Promoter Directing Tissue-Specific Cutting Edge: Identification of an Alternative

H. Asnagli, K. Murphy, M. Afkarian, 2002 .

Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.

A. Foussat, D. Klatzmann, H. Asnagli, 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T Cells.

A. Foussat, H. Asnagli, J. Gertner-dardenne, 2015, Investigative ophthalmology & visual science.

Peripheral T Cell Activation Program by Partial Agonist on Selection Events and Consequences of Intrathymic TCR Engagement

R. Flavell, S. Ghosh, H. Asnagli, 1998 .

SIGNALING AND TRANSCRIPTION IN

W. Ouyang, Jianfei Yang, J. Farrar, 2000 .

Signaling and transcription in T helper development.

W. Ouyang, Jianfei Yang, J. Farrar, 2000, Annual review of immunology.

T helper subset development: roles of instruction, selection, and transcription.

J. Farrar, H. Asnagli, K. Murphy, 2002, The Journal of clinical investigation.

The functional genomics experience (are you experienced?)

H. Asnagli, K. Murphy, Hélène Asnagli, 2001, Nature Immunology.